What is the connection between the immune system and psychiatric disorders?  What’s the investment landscape in neuroscience?  What are the next steps for Arialys?  Arialys President & CEO, Jay Lichter, Ph.D., answers these questions and more in this interview with Investment Reports. 

Read the Q&A here.